About the AGA Center for GI Innovation & Technology

Over the last decade several promising GI technologies have failed, in part, due to lack of guidance and support by the field. AGA recognizes that innovation and the development of new technology are integral to advancing the science and practice of gastroenterology and improving patient care and health outcomes for digestive diseases. AGA has established the AGA Center for GI Innovation and Technology to support the development of technology that can improve patient care under the guidance of evidence-based standards. The center will serve as an objective GI-specific resource to assist members, GI researchers, entrepreneurs and the medical device, therapeutics and investment communities in their work to bring new technology to the marketplace.

Through the center, AGA will work with key regulatory bodies and the commercial payor community to better understand their specific requirements for coverage, adoption and reimbursement and, in turn, will translate that information to the field.  Through the center, AGA will advocate for a transparent and fair process that does not stifle innovation.

By working collaboratively with our members, regulators and the medical device, therapeutics and investment communities to address the collective issues, AGA will support a healthy pipeline of evidence-based advancements in digestive disorders and the research, education, training and advocacy for gastroenterology to improve patient care.

Focused Activities

The center does not endorse any product or service. It is not an explicit industry advocate. AGA cannot guarantee that any product or service will be approved by FDA, and/or is adopted or will obtain coding, coverage, and/or reimbursement from governmental and private payors.

Objective Resource

Provide feedback and guidance related to whether there is a need to develop a new technology or device in a given area. AGA can also offer guidance on payor requirements, billing, and steps needed to obtain coverage and reimbursement.

Assessment of Peer-Reviewed Literature

AGA can assess literature for level of evidence, gaps and regulatory requirements (CMS, CTAF, private payors, etc.). AGA can also provide recommendations on additional studies and/or publications and development of training standards.

Identification of Experts

AGA can identify clinical investigators and provide expert reviews and assessments of peer-reviewed literature.

Education

Provide members, clinical investigators, medical device companies and investors with information to help them understand the requirements of private payors and policy makers, such as FDA, CMS and AHRQ.

Clinical Trial Design and Development

AGA can help support a companies need to obtain and gather data and evidence required by physician members, payors and regulatory agencies.

Training

Develop evidence-based training standards for new technologies and mechanisms for training.

Advocacy

Support and promote the development of equitable policies and payment for proven technologies.

Research

Promote evidence-based and outcomes driven research for new technologies.

White Papers

Commission the development of white papers addressing issues and/or plans of action for medical device development in gastroenterology.

Executive Committee and Strategic Advisory Board

The executive committee serves as the governing body that oversees all operations of the center; including the successful implementation, monitoring and ongoing management of resources and activities related to the center. Three subcommittees report to the executive committee and support the work of the center.

2017–2018 Executive Committee

V. Raman Muthusamy, MD, AGAF, FACG, FASGE Chair
Sri Komanduri, MD, AGAF Vice-Chair
Michael Kochman, MD, AGAF Past Chair
Ashish Atreja, MD, MPH  
Laurel R. Fisher, MD, AGAF  
Rajeev Jain, MD, AGAF  
Janak N. Shah, MD  

2017–2018 Registry Oversight Subcommittee

Ashish Atreja, MD, MPH            Chair
Steven D. Schwaitzberg, MD  
Sachin B. Wani, MD  

 2017–2018 Events and Communication Subcommittee

V. Raman Muthusamy, MD, AGAF, FACG, FASGE Chair
Michael L. Kochman, MD, AGAF Past Chair
Laurel R. Fisher, MD, AGAF  
Robert A. Ganz, MD  
Gene K. Ma, MD  
Sidhartha R. Sinha, MD  
Armita Sethi, MD  

2017–2018 Project Review and Oversight Subcommittee

Janak N. Shah, MD Chair
Neelendu Dey, MD  
Sri Komanduri, MD, AGAF  
Joshua Melson, MD  
V. Raman Muthusamy, MD, AGAF, FACG, FASGE  
Reem Sharaiha, MBBS, MRCP, MS  
   

Strategic Advisory Board

Consisting of representatives from industry and the investor communities, the strategic advisory board assists the executive committee with monitoring issues and trends, and identify areas that require education, advocacy and training. The panel also assists with development of the annual technology summit program.

Friends of the AGA Center for GI Innovation and Technology

Friends of the AGA Center for GI Innovation and Technology is a distinction given to those companies that make a significant multi-year financial commitment to support the center’s global efforts of fostering innovation and technology in digestive and metabolic diseases.

AGA thankfully acknowledges:

                                                   

Contact Us

For more information on the center’s activities, contact  Jennifer A. Conte, vice president of innovation and health economics.